4.7 Article

Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease

期刊

BRAIN
卷 142, 期 -, 页码 2380-2401

出版社

OXFORD UNIV PRESS
DOI: 10.1093/brain/awz172

关键词

zinc finger protein 746; PARIS; alpha-synuclein; parkin; Parkinson's disease

资金

  1. NIH/NINDS Morris K. Udall Parkinson's Disease Research Center [NS38377]
  2. NIH/NINDS [NS082205, NS098006]
  3. JPB Foundation
  4. Parkinson's Disease Foundation [PDF-SFW-1572, PDF-APDA-SFW-1650]
  5. American Parkinson Disease Association [PDF-SFW-1572, PDF-APDA-SFW-1650]
  6. Intramural Research Program of the NCI, Center for Cancer Research, NIH
  7. Foundation's Parkinson's Disease Program [M-1, M-2, H-2013, H-2014]
  8. NATIONAL CANCER INSTITUTE [ZIABC010390] Funding Source: NIH RePORTER

向作者/读者索取更多资源

alpha-Synuclein misfolding and aggregation plays a major role in the pathogenesis of Parkinson's disease. Although loss of function mutations in the ubiquitin ligase, parkin, cause autosomal recessive Parkinson's disease, there is evidence that parkin is inactivated in sporadic Parkinson's disease. Whether parkin inactivation is a driver of neurodegeneration in sporadic Parkinson's disease or a mere spectator is unknown. Here we show that parkin in inactivated through c-Abelson kinase phosphorylation of parkin in three alpha-synuclein-induced models of neurodegeneration. This results in the accumulation of parkin interacting substrate protein (zinc finger protein 746) and aminoacyl tRNA synthetase complex interacting multifunctional protein 2 with increased parkin interacting substrate protein levels playing a critical role in alpha-synuclein-induced neurodegeneration, since knockout of parkin interacting substrate protein attenuates the degenerative process. Thus, accumulation of parkin interacting substrate protein links parkin inactivation and alpha-synuclein in a common pathogenic neurodegenerative pathway relevant to both sporadic and familial forms Parkinson's disease. Thus, suppression of parkin interacting substrate protein could be a potential therapeutic strategy to halt the progression of Parkinson's disease and related alpha-synucleinopathies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据